ArticleMolecular cancer therapeutics2014

Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytes.

Zainul S Hasanali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.